您好, 歡迎來到化工儀器網(wǎng)! 登錄| 免費注冊| 產(chǎn)品展廳| 收藏商鋪|
當(dāng)前位置:首頁 >> 資料下載 >> Targeting HSP90 dimerization via theC terminus is effective in imatinib-resistant
提供商
上海協(xié)爍儀器科技有限公司資料大小
2.3MB資料圖片
下載次數(shù)
0次資料類型
PDF 文件瀏覽次數(shù)
199次Heat shock protein 90 (HSP90) stabilizes many client proteins, including the BCR-ABL1
oncoprotein. BCR-ABL1 is the hallmark of chronic myeloid leukemia (CML) in which
treatment-free remission (TFR) is limited, with clinical and economic consequences. Thus,
there is an urgent need for novel therapeutics that synergize with current treatment
approaches. Several inhibitors targeting the N-terminal domain of HSP90 are under investigation, but side effects such as induction of the heat shock response (HSR) and toxicity
have so far precluded their US Food and Drug Administration approval. We have developed a novel inhibitor (aminoxyrone [AX]) of HSP90 function by targeting HSP90 dimerization via the C-terminal domain.
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業(yè)自行提供,信息內(nèi)容的真實性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負責(zé),化工儀器網(wǎng)對此不承擔(dān)任何保證責(zé)任。
溫馨提示:為規(guī)避購買風(fēng)險,建議您在購買產(chǎn)品前務(wù)必確認供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。